Chesapeake Capital Corp IL bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 883 shares of the healthcare conglomerate's stock, valued at approximately $516,000.
A number of other hedge funds have also made changes to their positions in UNH. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the third quarter valued at $27,000. Global Wealth Strategies & Associates increased its position in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC grew its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after purchasing an additional 47 shares during the period. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $32,000. Finally, Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at about $31,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
NYSE UNH traded down $0.92 on Friday, hitting $592.23. 3,423,919 shares of the stock were exchanged, compared to its average volume of 3,119,612. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market capitalization of $545.02 billion, a PE ratio of 38.58, a P/E/G ratio of 1.74 and a beta of 0.58. The business's fifty day moving average is $582.84 and its 200 day moving average is $549.52. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm's revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.56 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group's dividend payout ratio is presently 54.72%.
Analyst Ratings Changes
A number of equities analysts have issued reports on the company. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th. Stephens dropped their price target on shares of UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. Morgan Stanley decreased their price target on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald increased their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a report on Wednesday, October 16th. Finally, Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $615.53.
Read Our Latest Report on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.